Viral quasispecies evolution

E Domingo, J Sheldon, C Perales - Microbiology and Molecular …, 2012 - Am Soc Microbiol
Evolution of RNA viruses occurs through disequilibria of collections of closely related mutant
spectra or mutant clouds termed viral quasispecies. Here we review the origin of the …

[HTML][HTML] HIV-1 antiretroviral resistance: scientific principles and clinical applications

MW Tang, RW Shafer - Drugs, 2012 - Springer
The efficacy of an antiretroviral (ARV) treatment regimen depends on the activity of the
regimen's individual ARV drugs and the number of HIV-1 mutations required for the …

Accurate sampling and deep sequencing of the HIV-1 protease gene using a Primer ID

CB Jabara, CD Jones, J Roach… - Proceedings of the …, 2011 - National Acad Sciences
Viruses can create complex genetic populations within a host, and deep sequencing
technologies allow extensive sampling of these populations. Limitations of these …

Antiretroviral therapy and management of HIV infection

PA Volberding, SG Deeks - The Lancet, 2010 - thelancet.com
Antiretroviral therapy of HIV infection has changed a uniformly fatal into a potentially chronic
disease. There are now 17 drugs in common use for HIV treatment. Patients who can access …

Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a …

L Wittkop, HF Günthard, F De Wolf, D Dunn… - The Lancet infectious …, 2011 - thelancet.com
Background The effect of transmitted drug resistance (TDR) on first-line combination
antiretroviral therapy (cART) for HIV-1 needs further study to inform choice of optimum drug …

Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine

T Cihlar, AS Ray - Antiviral research, 2010 - Elsevier
Twenty-five years ago, nucleoside analog 3′-azidothymidine (AZT) was shown to efficiently
block the replication of HIV in cell culture. Subsequent studies demonstrated that AZT acts …

Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis

JZ Li, R Paredes, HJ Ribaudo, ES Svarovskaia… - Jama, 2011 - jamanetwork.com
Context Presence of low-frequency, or minority, human immunodeficiency virus type 1 (HIV-
1) drug resistance mutations may adversely affect response to antiretroviral treatment (ART) …

[HTML][HTML] Applications of next-generation sequencing technologies to diagnostic virology

L Barzon, E Lavezzo, V Militello, S Toppo… - International journal of …, 2011 - mdpi.com
Novel DNA sequencing techniques, referred to as “next-generation” sequencing (NGS),
provide high speed and throughput that can produce an enormous volume of sequences …

[HTML][HTML] Within-host diversity of SARS-CoV-2 in COVID-19 patients with variable disease severities

HA Al Khatib, FM Benslimane, IE Elbashir… - Frontiers in cellular …, 2020 - frontiersin.org
Background: The ongoing pandemic of SARS-COV-2 has already infected more than eight
million people worldwide. The majority of COVID-19 patients either are asymptomatic or …

Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment–naive patients significantly impact treatment outcomes

BB Simen, JF Simons, KH Hullsiek… - The Journal of …, 2009 - academic.oup.com
Abstract Background Minor (ie,< 20% prevalence) drug-resistant human immunodeficiency
virus (HIV) variants may go undetected, yet be clinically important Objectives To compare …